Advertisement
Advertisement

RNTX

R

Rein Therapeutics, Inc. Common Stock

1.22
USD
Sponsored
+0.05
+4.27%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

1.20

-0.02
-2.05%

Rein Therapeutics, Inc. Common Stock Profile

About

Rein Therapeutics is a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications. Rein Therapeutics, formerly known as Aileron Therapeutics Inc., is based in AUSTIN, Texas.

Info & Links

CEO

Brian Windsor

Headquarters

12407 N. MOPAC EXPY., SUITE 250 #390
AUSTIN, TX 78758, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://www.reintx.com

Auditor

CBIZ CPAs P.C.

Share holders

117

Employees

10

Rein Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

93.26M

Enterprise Value

90.04M

Enterprise Value/EBITDA(ttm)

-4.11

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

26.76

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-510.35%

Return on Invested Capital(ttm)

-696.82%

Return on Assets(ttm)

-56.38%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-21.93M

Net Income Available to Common(ttm)

-49.87M

Diluted EPS(ttm)

-1.96

Share Statistics

Beta (5Y Monthly)

1.40

52-Week Change

-29.07%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

28.04M

Dividend Yield

0.00%

Float4

26.61M

% Held by Insiders

5.10%

% Held by Institutions

90.89%

Balance Sheet

Total Cash(mrq)

3.21M

Total Cash Per Share(mrq)

0.11

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.70%

Quick Ratio(mrq)

0.70%

Book Value Per Share(mrq)

-1.02

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.76

Free Cash Flow(ytd)

-19.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement